Cash & equivalents decreased 41.8%
Cash & equivalents changed -41.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -41.8% from the comparable as-filed period.
Inventory changed +69.9% from the comparable as-filed period.
Operating margin changed +184742 basis points from the comparable as-filed period.
Revenue changed +173.5% from the comparable as-filed period.
Selling, general & administrative changed -39.4% from the comparable as-filed period.
Stock-based compensation changed -69.4% from the comparable as-filed period.
Operating income changed +9.4% from the comparable as-filed period.
Net income changed +1.4% from the comparable as-filed period.
Research & development changed +1.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.